12,008 Shares in Scholar Rock Holding Corporation $SRRK Acquired by SG Americas Securities LLC

SG Americas Securities LLC purchased a new stake in shares of Scholar Rock Holding Corporation (NASDAQ:SRRK) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 12,008 shares of the company’s stock, valued at approximately $447,000.

Other large investors have also recently made changes to their positions in the company. MN Wealth Advisors LLC bought a new stake in shares of Scholar Rock in the 3rd quarter worth approximately $268,000. Moody Aldrich Partners LLC raised its position in Scholar Rock by 53.5% in the 3rd quarter. Moody Aldrich Partners LLC now owns 101,742 shares of the company’s stock worth $3,789,000 after purchasing an additional 35,481 shares during the period. Three Seasons Wealth LLC bought a new stake in Scholar Rock in the third quarter worth $400,000. E. Ohman J or Asset Management AB boosted its position in Scholar Rock by 8.2% during the third quarter. E. Ohman J or Asset Management AB now owns 69,887 shares of the company’s stock valued at $2,603,000 after buying an additional 5,319 shares during the period. Finally, Exchange Traded Concepts LLC grew its stake in shares of Scholar Rock by 17.3% during the third quarter. Exchange Traded Concepts LLC now owns 24,370 shares of the company’s stock valued at $908,000 after buying an additional 3,600 shares during the last quarter. 91.08% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, insider Mo Qatanani sold 136,462 shares of Scholar Rock stock in a transaction that occurred on Thursday, December 4th. The stock was sold at an average price of $45.21, for a total transaction of $6,169,447.02. Following the sale, the insider directly owned 108,964 shares in the company, valued at $4,926,262.44. The trade was a 55.60% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Keith Woods sold 16,746 shares of the company’s stock in a transaction on Tuesday, January 13th. The stock was sold at an average price of $42.70, for a total value of $715,054.20. Following the completion of the sale, the chief operating officer directly owned 583,254 shares in the company, valued at approximately $24,904,945.80. The trade was a 2.79% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 305,687 shares of company stock valued at $13,540,573 over the last quarter. 13.30% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on SRRK. BMO Capital Markets reissued an “outperform” rating and issued a $50.00 target price on shares of Scholar Rock in a research note on Friday, November 14th. JPMorgan Chase & Co. boosted their price objective on Scholar Rock from $46.00 to $47.00 and gave the company an “overweight” rating in a research report on Tuesday, November 18th. Citigroup assumed coverage on shares of Scholar Rock in a report on Friday, January 9th. They issued a “buy” rating and a $55.00 target price on the stock. Bank of America initiated coverage on shares of Scholar Rock in a research note on Thursday, October 9th. They issued a “buy” rating and a $53.00 target price on the stock. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Scholar Rock in a research report on Thursday. Four analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $50.14.

Scholar Rock Price Performance

Shares of Scholar Rock stock opened at $44.29 on Friday. The business has a 50 day moving average of $43.73 and a 200 day moving average of $37.32. Scholar Rock Holding Corporation has a 52 week low of $22.71 and a 52 week high of $48.28. The company has a market cap of $4.52 billion, a PE ratio of -14.06 and a beta of 0.63. The company has a quick ratio of 6.30, a current ratio of 6.30 and a debt-to-equity ratio of 0.41.

Scholar Rock (NASDAQ:SRRK) last issued its quarterly earnings data on Friday, November 14th. The company reported ($0.90) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.88) by ($0.02). During the same quarter last year, the firm earned ($0.66) EPS. As a group, equities research analysts forecast that Scholar Rock Holding Corporation will post -2.42 earnings per share for the current year.

About Scholar Rock

Scholar Rock is a clinical-stage biotechnology company focused on the discovery and development of protein therapeutics that selectively target growth factors involved in disease processes. The company’s research platform is designed to modulate endogenous growth factor activation and signaling with high specificity, aiming to restore normal biological function across a range of disorders. Scholar Rock’s approach is distinguished by its emphasis on engineering antibodies and biologics that interact with growth factor precursors or latent complexes rather than the active form, potentially offering improved safety and efficacy profiles.

The company’s lead program, SRK-015 (appercept), is an investigational monoclonal antibody targeting the activation of latent myostatin proproteins and is being evaluated for the treatment of spinal muscular atrophy (SMA).